College of Veterinary and Animal Sciences, Parbhani Department of Veterinary Pathology
College of Veterinary and Animal Sciences, Parbhani Department of Veterinary Pathology
ANAPLASMOSIS
Anaplasmosis, formerly known as gall sickness, traditionally refers to a disease of
ruminants caused by obligate intraerythrocytic bacteria of the order Rickettsiales,
family Anaplasmataceae, genus Anaplasma. Cattle, sheep, goats, buffalo, and some
wild ruminants can be infected with the erythrocytic Anaplasma. Anaplasmosis occurs
in tropical and subtropical regions worldwide (~40N to 32S), including South and
Central America, the USA, southern Europe, Africa, Asia, and Australia.The Anaplasma
genus also includes A phagocytophilum ,A bovis, andA platys,all of which invade blood
cells other than erythrocytes of their respective mammalian hosts. Bovine
anaplasmosis is of economic significance in the cattle industry.
Clinical Findings
Lesions
Lesions are typical of those found in jaundiced. Blood is thin and watery. The spleen is
characteristically enlarged and soft, with prominent follicles. The liver may be mottled
and yellow-orange. The gallbladder is often distended and contains thick brown or
green bile. Hepatic and mediastinal lymph nodes appear brown. There are serous
effusions in body cavities, pulmonary edema, petechial hemorrhages in the epi- and
endocardium, and often evidence of severe GI stasis. Widespread phagocytosis of
erythrocytes is evident on microscopic examination of the reticuloendothelial organs.A
significant proportion of erythrocytes are usually found tobe parasitized after death
due to acute infection
Diagnosis
Anaplasma marginale, bovine blood smearA marginale, together with the
hemoprotozoa Babesia bovis and B bigemina, are the causative agents of tick fever in
cattle. These three species have similar geographic distributions, except that an
aplasmosis occurs in the absence of babesiosis in the USA. Microscopic examination of
Giemsa-stained thin and thick blood films is critical to distinguish anaplasmosis from
babesiosis and other conditions that result in anemia and jaundice, such as
leptospirosis and theileriosis.Blood in anticoagulant should also be obtained for
hematologic testing. In Giemsa-stained thin blood films, Anaplasma spp appear as
dense, homogeneously staining blue-purple inclusions 0.31.0 m in diameter. A
marginale inclusions are usually located toward the margin of the infected erythrocyte,
whereas A central inclusion bodies are located more centrally. A caudatum cannot be
distinguished from A marginale using Giemsa-stained blood films. Special staining
techniques are used to identify this species based on observation of characteristic
appendages associated with the bacteria.A caudatum has been reported only in North
America and could possibly be a morphologic form of A marginale and not a separate
species. Inclusion bodies contain 18 initial bodies 0.30.4 m in diameter, which are
the individual rickettsiae. The percentage of infected erythrocytes varies with the stage
and severity of disease; maximum rickettsemias in excess of 50% can occur with A
marginale. Microscopically, the infection becomes visible 26 wk after transmission.
During the course of infection, the rickettsemia can double each day for up to 10 days
and then decreases. Severe anemia can persist for weeks after parasites cannot be
detected in blood smears. Chronically infected carriers may be identified with a fair
degree of accuracy by serologic testing using the msp5 ELISA, complement fixation, or
card agglutination tests.
Tetracycline antibiotics and imidocarb are currently used for treatment. Cattle may be
sterilized by treatment with these drugs and remain immune to severe anaplasmosis
subsequently for at least 8 mo.Prompt administration of tetracycline drugs
(tetracycline,
chlortetracycline,
oxytetracycline,
rolitetracycline,
doxycycline,
minocycline) in the early stages of acute disease (eg, PCV >15%) usually ensures
survival. A commonly used treatment consists of a single IM injection of long-acting
oxytetracycline at a dosage of 20 mg/kg. Blood transfusion to partially restore the PCV
greatly improves the survival rate of more severely affected cattle. The carrier state
may be eliminated by administration of a long-acting oxytetracycline preparation (20
mg/kg, IM, at least two injections with a 1-wk interval). Withholding periods for
tetracyclines apply in most countries. Injection into the neck muscle rather than the
rump is preferred.Imidocarb is also highly efficacious against A marginale as a single
injection (as the dihydrochloride salt at 1.5 mg/kg, SC, or as imidocarb dipropionate at
3 mg/kg). Elimination of the carrier state requires the use of higher repeated doses of
imidocarb (eg, 5 mg/kg, IM or SC, two injections of the dihydrochloride salt 2 wk apart).
Imidocarb is a suspected carcinogen with long withholding periods and is not approved
for use in the USA or Europe. In South Africa, Australia, Israel, and South America,
infection with live A centrale(originating from South Africa) is used as a vaccine to
provide cattle with partial protection against the disease caused by A marginale. A
centrale(single dose) vaccine produces severe reactions ina small proportion of cattle.
Q FEVER
veterinarians and small ruminant farmers is also high .The greatest risk of transmission
occurs at parturition by inhalation, ingestion, or direct contact with birth fluids or
placenta. The organism is also shed in milk, urine, and feces. High-temperature
pasteurization effectively kills the organism. Ticks may transmit the disease among
domestic ruminants but are not thought to play an epidemiologically important role in
transmission of disease to people.
significant risk period for transmission because of the large amount of environmental
contamination associated with abortion. Standard abortion control measures,
including prompt removal of aborted materials (using zoonotic precautions),
segregation of animals by pregnancy status, and diagnostic evaluation of abortions, are
all warranted. Zoonotic Risk Q fever occurs more frequently in persons who have
occupational contact with high-risk species. The clinical presentation in people is highly
variable clinically, ranging from a self-limiting, influenza-like illness to pneumonia,
hepatitis, and endocarditis. C burnetii is highly infectious, and a single organism can
reportedly cause infection via the aerosol route in people. ed milk. Handling of infected
tissue poses a threat to laboratory personnel.
AST, but a definitive diagnosis is only possible on liver biopsy, which shows the
characteristic fibrin ring granulomas.
Treatment
Prevention
vaccine, protective immunity lasts for many years. Revaccination is not generally
required. Annual screening is typically recommended.
Ehrlichiosis
Etiology
Canine monocytic ehrlichiosis is usually caused by the rickettsia Ehrlichia canis,
although other types of Ehrlichia are sometimes involved. (Rickettsiae are a specialized
type of bacteria that live only inside other cells.) Carried by ticks, the organism infects a
certain type of white blood cell and causes fever and other signs. A related organism,
Ehrlichia ewingi, targets other types of white blood cells called granulocytes and has
been isolated from dogs and people in the southern, western, and midwestern United
States. Anaplasma platys, another rickettsia, causes infectious cyclic thrombocytopenia
in dogs. This infection leads to periodic losses of platelets, which causes problems with
blood clotting.The Ehrlichia and Anaplasma rickettsiae are present in many parts of the
world, including the United States. They are transmitted by ticks (including the brown
dog tick, lone star tick, and black-legged tick) that become infected after feeding on
infected animals. People, dogs,cats, and other domestic animals are accidental hosts of
these disease-causing organisms.
In infections caused by Ehrlichia canis, signs commonly progress from short to long
term, depending on the strain of the organism and the immune status of the host. In
short-term cases, there is fever, widespread inflammation of the lymph nodes,
enlargement of the spleen, and a decrease in the number of platelets in the
bloodstream. In addition, there may be loss of appetite, depression, loss of stamina,
stiffness and reluctance to walk, swelling of the limbs or scrotum, and coughing or
difficulty in breathing. Most short-term cases are seen in the warmer months, when
ticks are active. During this phase of infection, death is rare and the infected animal
may recover spontaneously. The recovered dog may remain free of signs thereafter, or
long term disease may develop.Long term ehrlichiosis caused by Ehrlichia canis may
develop in any breed of dog, but certain breeds (such as German Shepherds) may be
predisposed. Long term infection does not vary with the seasons. Signs depend on
which organs are affected and may include enlargement of the spleen, kidney failure,
and inflammation of the lungs, eye, brain and spinal cord. If the brain and spinal cord
are involved, there may be problems with the nervous system, such as lack of
coordination, depression, partial paralysis, and increased sensitivity to a normally
painless touch. Severe weight loss is common.Dogs infected with Anaplasma platys
generally show minimal to no signs of infection, although the organism is present in
the platelets. Infection with other rickettsiae causes signs similar to short-term
Ehrlichia canis infection, but the disease is usually more self-limiting. Fever and a
lameness that shifts from one leg to another may be present. Longterm disease (such
as that seen with Ehrlichia canis infection) is not typically seen in other ehrlichial
Diagnosis
The most common symptoms include headache,muscle aches, and fatigue. A rash may
occur, but is uncommon. Ehrlichiosis can also blunt the immune system by suppressing
production of TNF-alpha, which may lead to opportunistic infections such as
candidiasis. Most of the signs and symptoms of ehrlichiosis can likely be ascribed to
the immune dysregulation that it causes. Late in infection, however, production of this
substance can be up regulated by 30 fold, which is likely responsible for the "toxic
shock-like" syndrome seen in some severe cases of ehrlichiosis. Some cases can
present with purpura and in one such case the organisms were present in such
overwhelming numbers that in 1991 Dr. Aileen Marty of the AFIP was able to
demonstrate the bacteria in human tissues using standard stains, and later proved that
the organisms were indeed Ehrlichia using immune peroxidase stains.Experiments in
mouse models further supports this hypothesis, as mice lacking TNF-alpha I/II
receptors are resistant to liver injury caused by ehrlichia infection.3% of human
monocytic ehrlichiosis cases result in death; however, these deaths occur "most
commonly in immune suppressed individuals who develop respiratory distress
syndrome, hepatitis, or opportunistic nosocomial infections.
Treatment
Doxycycline and minocycline are the medications of choice. For people allergic to
antibiotics of the tetracycline class, rifampin is an alternative. Early clinical experience
suggested that chloramphenicol may also be effective, however, in vitro susceptibility
testing revealed resistance.[citation needed.
Prevention
No human vaccine is available for ehrlichiosis. Tick control is the main preventive
measure against the disease. However, in late 2012 a breakthrough in the prevention
of CME (canine monocytic ehrlichiosis) was announced when a vaccine was accidentally
discovered by Prof. Shimon Harrus, Dean of the Hebrew University of Jerusalem's Koret
School of Veterinary Medicine.[